Literature DB >> 32675799

Disability Discrimination Against People With Substance Use Disorders by Postacute Care Nursing Facilities: It is Time to Stop Tolerating Civil Rights Violations.

Kelly K Dineen1.   

Abstract

People with substance use disorders (PWSUDs), including opioid use disorder (OUD), continue to face widespread discrimination, including in health care. As hospitals increasingly provide more appropriate and integrated care for PWSUDs, nursing facilities that provide postacute care are receiving more referrals for patients whose diagnosis of substance use disorders is acknowledged rather than ignored. A concerning number of these facilities refuse to admit or treat PWSUD, especially those with OUD receiving opioid agonist therapy (OAT). This practice violates multiple federal antidiscrimination laws. Postacute care nursing facilities, such a skilled nursing or rehabilitation facilities, must end discriminatory practices against PWSUDs. Legal actors, from government enforcers to public interest lawyers, should utilize existing laws to communicate that noncompliance is no longer tolerated and that the civil rights of PWSUDs matter.
Copyright © 2020 American Society of Addiction Medicine.

Entities:  

Mesh:

Year:  2021        PMID: 32675799     DOI: 10.1097/ADM.0000000000000694

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  2 in total

1.  Perceptions and Concerns of SUD Treatment Organizations Regarding the CARES Act's Alterations to Patient Confidentiality Regulations.

Authors:  Julia Ivanova; Michael Saks; George Karway; Anita Murcko; Candy Espino; Chase Millea; Melissa Soliz; Adela Grando
Journal:  Perspect Health Inf Manag       Date:  2022-03-15

2.  Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries.

Authors:  Patience Moyo; Melissa Eliot; Asghar Shah; Kimberly Goodyear; Eric Jutkowitz; Kali Thomas; Andrew R Zullo
Journal:  Addict Sci Clin Pract       Date:  2022-10-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.